Company intelligence / Profile preview
Enosi Life Sciences
San Diego, California, USAprnewswire.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
All pipeline programs are preclinical. No clinical results have been reported yet. The company has filed patents for its proprietary molecules EN1001, EN2001, and EN3001 targeting autoimmune diseases, cancer, acute inflammation, and fibrotic conditions. These therapeutics are designed to selectively inhibit harmful inflammatory pathways while sparing or enhancing beneficial immune functions.
- Therapeutic areas
- OncologyRare DiseasesImmunologyNeurologyInfectious Diseases
- Modalities
- Fusion proteinsMonoclonal antibodiesBiological productsAntibodies
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Danuo Science Group – partnership to develop the Growth Factor Trap (“EN‑2000 Program”) and TNFR1 Blocker (“EN‑1000 Program”) for Greater China; Danuo provides $5M upfront licensing fees plus conditional funding. Estimated value over $100M including development milestones.
Beyond the preview
Go deeper on Enosi Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Enosi Life Sciences.